Charts
28 Jan, 2023
27 Jan, 2023
17:55
Seeking Alpha
26 Jan, 2023
18:00
Seeking Alpha
24 Jan, 2023
23 Jan, 2023
21 Jan, 2023
20 Jan, 2023
19 Jan, 2023
18 Jan, 2023
News
19 Dec, 2022
18:38
FinancialContent
Gainers
Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares jumped 259% to $229.35 after the company announced resmetirom ...
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland – December 19, 2022 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies for women’s health, today announced that the competent court in Geneva, Switzerland has granted the Company’s request to withdraw its moratorium considering that the Company is no longer over-indebted. The Company resolved its over-indebtedness due to the previously announced
11:13
FinancialContent
Gainers
AIM ImmunoTech Inc. (NYSE: AIM) shares rose 82.4% to $0.62 in pre-market trading. AIM ImmunoTech recently reported safety, ...
14 Dec, 2022
12:00
Yahoo! Finance
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland – December 14, 2022 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies for women’s health, announced today announced an update on its progress towards meeting Nasdaq’s minimum stockholders’ equity requirement. As previously announced, on August 19, 2022, the Company received a letter (the “Nasdaq Letter”) from the Nasdaq Stock Exchange (“Nasdaq”)
11:30
FinancialContent
Gainers
Vallon Pharmaceuticals, Inc. (NASDAQ: VLON) shares rose 150.9% to $0.6313 in pre-market trading after the company entered ...
09 Dec, 2022
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland – December 9, 2022 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies for women’s health, announced today that its board of directors approved on December 8, 2022 an increase of its share capital through the issuance of 20,000,000 newly registered shares at an issue price of 1/13 of a Swiss Franc each. The 20,000,000 new shares, to be issued out
02 Dec, 2022
18:27
FinancialContent
Gainers
Yunhong CTI Ltd. (NASDAQ: CTIB) rose 42% to $0.54 after dipping 56% on Thursday.
Top Ships Inc. (NASDAQ: TOPS) rose ...
12:49
FinancialContent
Gainers
Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) shares rose 44.7% to $0.9902 in pre-market trading after the company reported ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
We're starting off the day with an overview of the biggest pre-market stock movers traders need to know about for Friday morning!
The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday appeared first on InvestorPlace.
More From InvestorPlace
Buy This $5 Stock BEFORE This Apple Project Goes Live
The Best $1 Investment You Can Make Today
Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air”
It doesn’t matter if you have $500 or $5 million. Do this now.
01 Dec, 2022
ObsEva SA (OBSV) delivered earnings and revenue surprises of 7.14% and 100%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
21:01
Yahoo! Finance
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland – December 1, 2022 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN) (“ObsEva” or the “Company”), a biopharmaceutical company developing novel therapies for women’s health, today reported financial results for the third quarter ended September 30, 2022 and provided a business update. “We are pleased to have neared the completion of a restructuring process that allowed us to generate an important influx of capital, posit
23 Nov, 2022
12:38
FinancialContent
Gainers
COMSovereign Holding Corp. (NASDAQ: COMS) shares rose 58.4% to $0.1069 in pre-market trading after gaining more than 16% ...
10:25
FinancialContent
Gainers
Cosmos Holdings Inc. (NASDAQ: COSM) jumped 86.9% to close at $0.3275 on Tuesday after jumping 21% on Monday. Cosmos Health ...
22 Nov, 2022
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 300 points on Tuesday.
The Dow traded up ...
18:16
FinancialContent
Gainers
Palisade Bio, Inc. (NASDAQ: PALI) shares jumped 99.1% to $4.42 after the company announced the FDA granted Fast Track ...
U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 250 points on Tuesday.
The Dow traded up 0.83% ...
12:27
FinancialContent
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
It's time to start the day with an overview of the biggest pre-market stock movers traders need to know about for Tuesday morning!
The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday appeared first on InvestorPlace.
More From InvestorPlace
Buy This $5 Stock BEFORE This Apple Project Goes Live
The Best $1 Investment You Can Make Today
Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air”
It doesn’t matter if you have $500 or $5 million. Do this now.
12:00
Yahoo! Finance
Sale of Ebopiprant royalty and milestone license to XOMA includes upfront payment of $15 million and future milestone payments of up to $98 millionThe sale proceeds are expected to enable ObsEva to resolve its current over-indebtedness position and to withdraw its pending Swiss moratorium proceedingsSale proceeds expected to position ObsEva to satisfy Nasdaq stockholders’ equity requirement for continued public listingObsEva expects to have greater than one year of cash runway, providing strateg
11:22
FinancialContent
Gainers
ObsEva SA (NASDAQ: OBSV) shares rose 71.9% to $0.2848 in pre-market trading after the company reported the sale of ...
14 Nov, 2022
Companies Reporting Before The Bell
• Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on ...
04 Nov, 2022
26 Oct, 2022
21:00
Yahoo! Finance
Transition of linzagolix program to Kissei Pharmaceutical Co., Ltd. substantially complete with approximately $16.0 million savings expected from assignment of program contracts, including $3.7 million of accounts payable assigned to date Company extends forbearance agreement with JGB through December 1, 2022Swiss court grants stay of moratorium proceedings through November 30, 2022, as ObsEva progresses restructuring initiatives Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchan
13 Oct, 2022
11:00
Yahoo! Finance
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland – October 13, 2022 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing novel therapies for women’s health, today announced that Yuyuan Bioscience’s (Yuyuan) IND application for a Phase 1 clinical trial of nolasiban has been approved by the Center for Drug Evaluation at the Chinese National Medical Products Administration. Nolasiban is a novel, oral oxytocin receptor antagonist being
10:06
FinancialContent
Gainers
Pintec Technology Holdings Limited (NASDAQ: PT) shares jumped 216.2% to close at $0.9058 on Wednesday.
Agrify ...
12 Oct, 2022
16:00
FinancialContent
Gainers
Code Chain New Continent Limited (NYSE: CCNC) shares jumped 74% to $0.2868 after declining around 14% on Tuesday.
FLJ ...
Gainers
Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) rose 43.2% to $0.2097 in pre-market trading after jumping over 16% on ...
05 Oct, 2022
10:54
FinancialContent
Gainers
Vicinity Motor Corp. (NASDAQ: VEV) rose 65.4% to $1.72 in pre-market trading. Vicinity Motor started deliveries of the ...
13 Sep, 2022
After running into a major roadblock at the FDA for its uterine fibroid drug,ObsEva SA(NASDAQ: OBSV) hasflagged ...
$7.6 million annual savings expected via reduction-in-force currently underway$6.2 million savings expected from assignment of legacy linzagolix program contracts to Kissei Pharmaceutical Co., Ltd., including $1.7 million of accounts payable assigned to date. Additional assignments are expected in the coming weeks.Company submitted plan to regain compliance with Nasdaq’s minimum stockholders’ equity rule. Additionally, Nasdaq provides notice of noncompliance with Nasdaq’s minimum bid price listi
06 Sep, 2022
Gainers
First Wave BioPharma, Inc. (NASDAQ: FWBI) shares rose 39.6% to $4.44 in pre-market trading after gaining 7% on ...
01 Sep, 2022
16:47
FinancialContent
Gainers
ShiftPixy, Inc. (NASDAQ: PIXY) jumped 94.4% to $27.24. ShiftPixy announced a 1-for-100 reverse stock split.
Hempacco ...
Gainers
Bright Green Corporation (NASDAQ: BGXX) shares rose 63.8% to $2.26 in pre-market trading after gaining around 33% on ...
Gainers
Nuwellis, Inc. (NASDAQ: NUWE) shares climbed 121.3% to close at $1.46 on Wednesday after the company announced new ...
31 Aug, 2022
18:52
FinancialContent
After August’s mixed tally for Food and Drug Administration approvals, investors turn to a new month, which has a fairly loaded ...
30 Aug, 2022
18:56
FinancialContent
HC WainwrighthasdowngradedObsEva SA(NASDAQ: OBSV) from a Buy to Neutral without a price target.
Late last ...
22 Aug, 2022
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange Geneva, Switzerland and Boston, MA – August 22, 2022 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a biopharmaceutical company developing novel therapies to improve women’s reproductive health, today announced that on August 19, 2022 it received a notification letter from The Nasdaq Stock Market (“Nasdaq”) advising the Company that it was not in compliance with Listing Rule 5450(b)(1)(A) requiring companies listed on the Nasdaq Globa
17 Aug, 2022
ObsEva (NASDAQ:OBSV) reported its Q2 earnings results on Wednesday, August 17, 2022 at 04:00 PM.
Here's what investors ...
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange Geneva, Switzerland and Boston, MA – August 17, 2022 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive health, today published its Second Quarter 2022 Financial Statements. The Second Quarter 2022 Financial Statements may be found on the financial section of the Company’s website, here or directly via the link here. About ObsEva Obs
10 Aug, 2022
11:20
FinancialContent
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
It's time for another dive into the biggest pre-market stock movers as we check out the latest news for Wednesday morning!
The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday appeared first on InvestorPlace.
More From InvestorPlace
Buy This $5 Stock BEFORE This Apple Project Goes Live
The Best $1 Investment You Can Make Today
Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air”
It doesn’t matter if you have $500 or $5 million. Do this now.
Gainers
ObsEva SA (NASDAQ: OBSV) shares rose 33.8% to $0.4080 in pre-market trading. ObsEva recently announced a $31 million debt ...
08 Aug, 2022
Companies Reporting Before The Bell
• Pyxis Tankers (NASDAQ:PXS) is likely to report earnings for its second ...
03 Aug, 2022
ObsEva SA (OBSV) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
02 Aug, 2022
Tuesday's session saw 63 companies set new 52-week lows.
Noteable 52-Week Lows:
The largest company by market cap ...
01 Aug, 2022
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland – August 1, 2022 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing novel therapies for women’s health, today announced the early retirement of $31 million in debt that was part of amounts owed to certain funds and accounts managed by JGB Management, Inc. (JGB) pursuant to the Company’s Securities Purchase Agreement with JGB. Additionally, the Company has entered into an amendment
09:27
FinancialContent
Gainers
Getty Images Holdings, Inc. (NYSE: GETY) shares climbed 149.1% to close at $26.15 on Friday following its merger with ...
29 Jul, 2022
17:05
FinancialContent
Gainers
Getty Images Holdings, Inc. (NYSE: GETY) shares jumped 106.7% to $21.69 after nearly 99.4% of shares were redeemed by ...
Gainers
Getty Images Holdings, Inc. (NYSE: GETY) rose 104.5% to $21.47 in pre-market trading.
ThermoGenesis Holdings, Inc. ...
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland – July 29, 2022 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing novel therapies for women’s health, today announced the resignation of Jean-Pierre Gotteland, Chief Scientific Officer and Head of Research & Development, effective September 30, 2022. Dr. Gotteland will step down from the Company's Executive Committee, effective immediately. “On behalf of the Board of Directors, Ex
28 Jul, 2022
08:22
FinancialContent
Gainers
Blue Water Vaccines, Inc. (NASDAQ: BWV) shares climbed 53.2% to close at $3.14 on Wednesday. Blue Water Vaccines recently ...
27 Jul, 2022
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 150 points on Wednesday.
The Dow traded up ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Pagaya Technologies (PGY) stock is rocketing higher on Wednesday despite a lack of news from the AI credit analysis company.
The post Pagaya Technologies (PGY) Stock Rockets Another 30% Higher appeared first on InvestorPlace.
More From InvestorPlace
Buy This $5 Stock BEFORE This Apple Project Goes Live
The Best $1 Investment You Can Make Today
Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air”
Cash Holders Could Get Hit Hard THIS FRIDAY
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 300 points on Wednesday.
The Dow traded ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Archer Aviation (ACHR) stock is rising higher on Wednesday after the eVTOL company reached an agreement with Honeywell International (HON).
The post Why Is Archer Aviation (ACHR) Stock Up 8% Today? appeared first on InvestorPlace.
More From InvestorPlace
Buy This $5 Stock BEFORE This Apple Project Goes Live
The Best $1 Investment You Can Make Today
Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air”
Cash Holders Could Get Hit Hard THIS FRIDAY
Wednesday saw 83 companies set new 52-week lows.
Areas of Interest About Today's 52-Week Lows:
Orange (NYSE:ORAN) ...
16:07
FinancialContent
Gainers
Blue Water Vaccines, Inc. (NASDAQ: BWV) shares jumped 67.8% to $3.4390. Blue Water Vaccines recently announced signing of ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
For small-cap biotech firms, having issues with the FDA can be problematic. OBSV stock holders are learning this lesson the hard way today.
The post Why Is ObsEva (OBSV) Stock Down 70% Today? appeared first on InvestorPlace.
More From InvestorPlace
Buy This $5 Stock BEFORE This Apple Project Goes Live
The Best $1 Investment You Can Make Today
Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air”
Cash Holders Could Get Hit Hard THIS FRIDAY
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland – July 27, 2022 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing novel therapies for women’s health, today announced that it plans to initiate a corporate restructuring and refocus the Company’s development and commercialization strategy. ObsEva believes the changes are necessary due to the commercial landscape and potential additional capital needed to fund the completion of the
10:34
FinancialContent
Gainers
Dave Inc. (NASDAQ: DAVE) rose 56.9% to $0.9826 in pre-market trading. Dave is expected to release its second quarter 2022 ...
05 Jul, 2022
29 Jun, 2022
16:06
FinancialContent
Here's a roundup of top developments in the biotech space over the last 24 hours:
Stocks In Focus
Eli Lilly To Supply ...
28 Jun, 2022
20:01
Yahoo! Finance
-Yselty® (linzagolix) is the first and only approved GnRH antagonist to provide flexible dosing options with and without hormonal add-back therapy- -Theramex to commercialize Yselty®; ObsEva to receive royalties on commercial sales, as well as development, commercial, and sales-based milestone payments- -Approval by MHRA follows the European Commission’s marketing authorization, granted in June 2022- Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland – June
21 Jun, 2022
In this article, we discuss the 10 unknown biotech stocks that can explode in 2022. If you want to read about some more biotech stocks that can explode in 2022, go directly to 5 Unknown Biotech Stocks That Can Explode in 2022. As coronavirus cases recede across the world and countries open up their borders […]
17 Jun, 2022
15:15
FinancialContent
Here's a roundup of top developments in the biotech space over the last 24 hours:
Stocks In Focus
Addex Stops ...
ObsEva's (OBSV) Yselty receives its first marketing approval in the European Union for the treatment of uterine fibroids in adult women. Shares were up 11% in pre-market trading following the news.
Gainers
Athersys, Inc. (NASDAQ: ATHX) rose 48.5% to $0.4755 in pre-market trading after dropping more than 12% on ...
12 Jun, 2022
A security pattern traces the distinct movements of security prices that, once recognized, help traders to make informed trading decisions. Let's look at some penny stock opportunities by analyzing these patterns.
07 Jun, 2022
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Invesco Nasdaq Biotechnology ETF (IBBQ), we found that the implied analyst target price for the ETF based upon its underlying holdings is $28.97 per unit.
17 May, 2022
10 Mar, 2022
10 Feb, 2022
04 Feb, 2022
01 Feb, 2022
28 Jan, 2022
06 Jan, 2022
17 Dec, 2021
13 Dec, 2021
22 Nov, 2021
04 Nov, 2021
29 Oct, 2021
13 Oct, 2021
15 Sep, 2021
10 Aug, 2021
05 Aug, 2021
04 Aug, 2021